SPA-10091-HCl
Product Specifications
Target
DOT1
Applications
Epigenetics
Additionnal Information
SPA-10091-HCl is a degrader of DOT1L that selectively degrades DOT1L protein through the nuclear ubiquitin-proteasome pathway, thereby suppressing H3K79 methylation in CRPC cells. It also inhibits DOT1L enzymatic activity with an IC50 of 0.87 μM, induces apoptosis, and significantly reduces tumor growth in vivo.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471927-500 1x 500 µL
SOX9 / SRY-box 9 (PCRP-SOX9-1A2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details